New treatment option for Heart Failure
Official title Impact of a Physical Exercise Program on the Self-care Capacity of People Hospitalized for Heart Failure
ClinicalTrials.gov ID: NCT06528561
What this study is testing
- What it's testing
- The objective of the study is to evaluate the effectiveness of a self-care program that integrates physical exercise with components of aerobic and muscular strength training in improving functional capacity and muscular strength in people hospitalized for decompensated heart failure, in a clinical stabilization phase The main question it aims to answer is: Is the Self-care program that integrates physical exercise with aerobic and muscular strength training components effective in improving the capacity for self-care in people hospitalized for decompensated HF, in the clinical stabilization phase? In this randomized clinical trial, the Self-Care program will be applied in the experimental group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants: Clinical diagnosis of decompensated HF, regardless of etiology or ventricular function;
- Participants: Be over 18 years old;
- Participants: Be able to provide informed consent.
You likely can't join if
- (participants):
- Osteoarticular pathology that causes physical limitations that prevent the performance of physical exercise;
- Existence of intravenous inotropic medication;
- Uncontrolled auricular or ventricular arrhythmias;
- Chest pain in the last 8 hours;
- Heart rate greater than 120;
See the full eligibility criteria
- Participants: Clinical diagnosis of decompensated HF, regardless of etiology or ventricular function;
- Participants: Be over 18 years old;
- Participants: Be able to provide informed consent.
- (participants):
- Osteoarticular pathology that causes physical limitations that prevent the performance of physical exercise;
- Existence of intravenous inotropic medication;
- Uncontrolled auricular or ventricular arrhythmias;
- Chest pain in the last 8 hours;
- Heart rate greater than 120;
- Dyspnea at rest;
- Uncontrolled blood pressure - Systolic blood pressure greater than 180mmHg or diastolic blood pressure greater than 110mmHg;
- 2nd or 3rd degree atrioventricular block;
- Oxygen need at a rate greater than 3L/min;
- Glycemic decompensation in the last 12 hours.
The study team makes the final eligibility decision.
Where it's taking place
- Porto, Portugal
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.